← Back to Vaccine Database

Recombinant protein vaccine S-268019 (using Baculovirus expression vector system)

Protein based vaccine · VDDBV0641

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT05212948 Phase 3COVID-19